GlassScriptPhysician profile
Seth G Spotnitz
NPI 1649243049
$2,039.73
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $854 · 2021: $156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $434.99 | 2019-2020 | |
| Biogen, INC. | $270.80 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $198.73 | 2019-2020 | |
| Emd Serono, INC. | $167.04 | 2019-2020 | |
| Amgen INC. | $122.55 | 2019-2020 | |
| Allergan, INC. | $114.32 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $106.70 | 2019 | |
| Lilly USA, LLC | $84.70 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $83.86 | 2019-2020 | |
| Ucb, INC. | $64.97 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $56.84 | 2020-2021 | |
| Mdd US Operations, LLC | $46.92 | 2019-2020 | |
| Sk Life Science, INC. | $36.58 | 2020 | |
| Lundbeck LLC | $35.95 | 2020 | |
| Pfizer INC. | $31.24 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $25.00 | 2021 | |
| Grifols USA, LLC | $23.08 | 2019 | |
| Ge Healthcare | $20.71 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.72 | 2020 | |
| Alexion Pharmaceuticals, INC. | $17.68 | 2019 | |
| Kyowa Kirin, INC. | $16.10 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.93 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.66 | 2021 | |
| Acadia Pharmaceuticals INC | $12.30 | 2020 | |
| Adamas Pharmaceuticals, INC. | $12.20 | 2020 | |
| Boston Scientific Corporation | $12.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Spotnitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.